Boerger Research Fund for Alzheimer’s Disease and Neurocognitive Disorders

Program Objectives

The American Society of Neuroradiology funds imaging-based research that advance our understanding of Alzheimer’s disease, help identify new treatment strategies, provide information to improve care for people with dementia, and further our knowledge of brain health and disease prevention. Our awards support investigators at every professional stage and always include categories specifically designed to help talented young scientists establish careers in Alzheimer’s imaging research.


General considerations: All proposals must have a clear focus on Alzheimer’s disease and may also include other neurodegenerative diseases. Ultimately, the goal of this program is to translate the research into strategies to increase understanding of the mechanism of Alzheimer’s disease to help stratify populations and possible treatments. Therefore, animal studies are not appropriate for this request for applications (RFA). Submissions from collaborative research that have experience across aging and neurodegenerative diseases are strongly encouraged. Novel and creative ideas are sought, and proposals should also demonstrate feasibility.

Available Funding: The ASNR anticipates funding multiple awards under this program. Applicants may request up to two years and $250,000 in total costs, inclusive of both direct and indirect costs. Exceptions for particularly unique projects will be considered, but requests that exceed $100,000 must be well justified in the Budget Justification section of the application. Budgets that exceed $100,000 require pre- approval by the Chairs of the Research committee prior to submission (please email pre-approval requests to rbhala@asnr.org). Indirect costs may not exceed 10 percent of directcosts.

Eligibility: Any member of the ASNR (in any category) in good standing can apply for this grant. Neuroradiologists (MD and/or PhD) and scientists (PhD) with faculty appointments are encouraged to apply, including instructor, assistant, associate and full professor levels. Clinical neuroradiology fellows and post-doctoral fellows are eligible to apply as a principal investigator (PI), but must collaborate with an administrative PI who serves as the director of the laboratory in which the research will be conducted. The administrative PI will be responsible for assisting in providing all institutional documents required for the project and will be required to sign any award contract. Training or mentoring-only proposals will not beconsidered.

Application Deadline: Applications must be received by 9:00 AM CST, January 31, 2017.


Budget and allowable costs: It is required that funds awarded under this program be used for direct research support. Budgets must be appropriate and justifiable for the work described. Funds awarded may be used for:

  • Salary for the principal investigator, scientific (including post-doctoral fellows) and technical staff (including laboratory technicians and administrative support staff whose work is directly related to the fundedproject).
  • Imaging costs
  • Laboratory supplies
  • Travel

Funds awarded cannot be used for:

  • Tuition
  • Computer hardware or software for investigators and other capitalequipment
  • Rent for laboratory/officespace
  • Construction or renovationcosts

Grant awardees will be notified shortly after the Annual Scientific Meeting of the ASNR (April 22-April 27, 2017). Projects can commence on July 1, 2017. No funds will be disbursed prior to demonstration of IRB approval of the proposed work.

Grant Recipients


Congratulations to the following recipients of the first ASNR Alzheimer’s Imaging Research Program grants.

2017

Michael Zeineh, MD, PhD
Stanford University

Amount Funded: $250,000.00

Iron-Based Neuroinflammation: A New Window to AD Pathology


2017

Cyrus Raji, MD, PhD
University of California, San Francisco

Amount Funded: $99,460.00

Diffusion MR Imaging based Edge Density Connectome Mapping for Prediction of Alzheimer’s Disease


2017

Sumit Niogi, MD, PhD
Joan & Sanford I. Weill Medical College of Cornell University

Amount Funded: $242,140.00

Development of a Clinically Integrated Prognostic Tool for Alzheimer’s Disease Using Deep Machine Learning Operating on a Connectome Network Diffusion Model


2017

Christopher G Filippi, MD
The Feinstein Institute for Medical Research

Amount Funded: $100,000.00

Development of a Novel, Quantitative MR Imaging Biomarker of Glymphatic Flow for Alzheimer’s Disease


2017

Elizabeth Davenport, PhD
University of Texas Southwestern

Amount Funded: $99,952.00

MEG Spectral Analysis as a Biomarker in Alzheimer’s Disease


2016

David J. Mikulis, MD
Toronto Western Hospital, University of Toronto
Bruce A. Wasserman, MD
Johns Hopkins School of Medicine

Amount Funded: $229,650.00

Developing an imaging biomarker for Alzheimer’s dementia based on vascular dysfunction


2016

Rahul Desikan, MD, PhD
University of California, San Francisco

Amount Funded: $230,865.00

Multi-dimensional prediction of Alzheimer’s disease risk


2016

Jeffrey R. Petrella, MD
Duke University School of Medicine

Amount Funded: $230,426.00

High-Resolution Intracortical DTI for Early Detection of Alzheimer’s Disease


2016

Meng Law, MD, MBBS, FRACR
University of Southern California

Amount Funded: $205,945.00

Multi-Shell HARDI/FOD and Structural MRI of White and Gray Matter Connectomics with Allopregnanolone Regenerative Therapy in MCI and Alzheimers Disease


2016

Sterling C. Johnson, PhD
University of Wisconsin School of Medicine and Public Health

Amount Funded: $100,000.00

Tau, amyloid and cerebral vascular health in people at risk for Alzheimer’s Disease